Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Amir Lerman, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01067339
First received: February 9, 2010
Last updated: January 7, 2016
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)